98% Purity Injectable Growth Hormone Peptides Powder Adipotide Weight Loss Polypeptides for Bodybuilding

본문 바로가기


Home > Product > 98% Purity Injectable Growth Hormone Peptides Powder Adipotide Weight Loss Polypeptides for Bodybuilding
Product
98% Purity Injectable Growth Hormone Peptides Powder Adipotide Weight ...
Posting date : Sep 05, 2018
Membership
Free Member Scince Sep 04, 2018
FOB Price
1 USD/Gram
Min. Order Quantity
10 Gram
Supply Abillity
5000KG/month
Port
HongKong, Shenzhen, Shanghai, Nanjing, Wuhan.etc
Payment Terms
Western Union, Moneygram, T/T, Bitcoin
Package
1kg/25kg/package
Keyword :
Category
Contact
Jennifer Jiang
Product Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
NJBN
HS-CODE
2937-19
Package & Delivery Lead Time
Package
1kg/25kg/package
Delivery Lead Time
Within 24 hours after confirming your payment
Detailed Description
98% Purity Injectable Growth Hormone Peptides Powder Adipotide Weight Loss Polypeptides for Bodybuilding
 
Quick Details for Adipotide
 
Product Name: Adipotide
Sequence:H-Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-Asp-(Lys-Leu-Ala-Lys-Leu-Ala-Lys)2
Molecular Formula: C111H204N36O28S2
Molar Mass: 2555.22 g/mol
Assay: 98%min
Appearance: White crystalline powder
Specification: 1g/foil bag
Minimum Order Quantity: 10g
Usage: Adipotide is often described as a peptide - however, it is not a peptide.
Storage: Store in cool and dry area and keep away from direct sunlight.
 
Product Description:
 
Aditpotide is an experimental weight loss peptidomimetic with the amino acid sequence CKGGRAKDC-GG-D(KLAKLAK)2, which has been developed by researchers in the United States in an effort to fight obesity. Peptidomimetics are small protein-like chains designed to mimic a peptide. The peptide called Adipotide has been developed by U.S. researchers in the fight against the obesity . This experimental treatment has reduced by 11% the weight of the treated monkeys by reducing fatty tissue, the BMI, and waist circumference.
 
Product Applications:
 
1)Epitalon decreases the age-related changes in immune and neuroendocrine systems, reduces the incidence of recurrent infections and chronic diseases.
2)Long term clinical trials have shown that in patients with age-related pathology Epithalamin eliminates imbalance in prooxidation and antioxidation systems.
3)Epithalon in patients with signs of accelerated aging showed normalizing effect on metabolism and condition of various functional systems. Elevated uric acid, alkaline phosphatase and cholesterol in elder patients returned to normal after 10 days of treatment, and remained stable in a several months peroid afterwards.
 
Product Dosage and Course (cycle) Duration:
 
Dosage depends on the purpose and severity of the damage which is treated. Epitalon can be used orally (less effective and large dose) or injected intramuscularly or under the skin (more effective at much smaller dose).
1)Oral Epithalon use (least effective):duration: between 10 - 20 daysdosage: between 400 - 600 mg of Epithalon per daydaily frequency:200 mg per serving, between 2 - 3 servings per day (depending on the dosage)
2)Epithalon as nasal spray or drops (medium effectiveness):duration: between 10 - 20 daysdosage: between 15 - 30 mg of Epithalon per daydaily frequency:total daily dosage split into 3 servings throughout the day
3)Injectable Epithalon use (most effective):duration: 10 - 20 daysdosage: between 5 - 10 mg per day (20 mg intravenous for terminal patients)frequency of injection:1 injection per day for low dose, 2 injections for higher dose (divided between morning and late afternoon injection)Each 10 - 20 days course of Epithalamin is followed by 4-6 months pause before repeating the course again. Epitalon treatment can be repeated indefintely.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO Park Jae Woo, TEL : +82-2-552-7676, E-mail : info@ecrobot.com
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Words of greeting Privacy Policy Terms of use Copyright © 2000-2019 ECROBOT.COM. All rights reserved.
Top